Source news

dow-jones News

20 stories
CNNE
dow-jones

Cannae Holdings, Inc. Acquires 100% of Exeter Rugby Group, Accelerating Its Strategy of Concentrating on Sports and Entertainment Assets

(12:30 GMT) *Cannae Holdings, Inc. Acquires 100% of Exeter Rugby Group, Accelerating Its Strategy of Concentrating on Sports and Entertainment Assets (12:32 GMT) Press Release: Cannae Holdings, Inc. Acquires 100% of Exeter Rugby Group, Accelerating Its Strategy of Concentrating on Sports and Entert…

Dow Jones Newswires en
StocksGB
VEON
dow-jones

VEON's USD 250 Million Anchor Investment Aims to Attract USD 1 Billion for Bangladesh

Dubai, Dhaka, and New York, June 30, 2026: VEON Ltd. NASDAQ:VEON, a global digital operator and the parent company of Banglalink, committed an initial USD 250 million investment over the coming years, forming part of a new initiative aimed at attracting a total of USD 1 billion in foreign direct in…

Dow Jones Newswires en
EconomyStocksBD
CAGDP
dow-jones

Canada GDP Grows 0.5% in April

By Robb M. StewartOTTAWA--The Canadian economy in April notched its strongest growth in nine months as oil and gas extraction and manufacturing rebounded.Gross domestic product, a broad measure of goods and services produced across the economy, increased 0.5% from the month before to 2.353 trillion…

Dow Jones Newswires en
Economy
UBSG
dow-jones

Europeans Get Wealthier, But Lag Behind Americans — WSJ

By Margot PatrickEuropeans got richer last year, but they're still not even halfway to the average wealth enjoyed by Americans, according to UBS's Global Wealth Report. European average wealth per adult last year was $337,083, compared with $696,277 in the U.S.Year on year, wealth gain was 17% in W…

Dow Jones Newswires en
Economy
NEWS dow-jones

Yomiuri: Japan Eyes Policy to Promote Dual-Use Tech Creation

The Yomiuri ShimbunThe Japanese government has set out a policy to establish hubs of industry, government and academia at state research institutions to promote the development of dual-use technologies, such as artificial intelligence and semiconductors.According to the draft of the 2026 Integrated…

Dow Jones Newswires en
Economy
VTGN
dow-jones

Vistagen Therapeutics Says Fasedienol Didn't Meet Primary Endpoint in Study

By Freddy SebastianVistagen Therapeutics said its fasedienol nasal spray didn't achieve its primary endpoint in a trial for the acute treatment of social anxiety disorder.The company said Tuesday there was no treatment difference between fasedienol and placebo for the secondary endpoints.Favorable…

Dow Jones Newswires en
StocksUS